Summit Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Miami, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Summit Therapeutics Inc. has filed 543 SEC EDGAR filings since 04 Mar 2014

SEC filing history

Showing 1-25 of 543 matching filings.

Per page
25
Current page
1
4

FORM 4

Filing date
12 Jun 2026
Reporting date
12 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Jun 2026
Reporting date
12 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-296642

424B5

Filing date
10 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-296642

S-3ASR

Filing date
09 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36866

ARS

Filing date
17 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36866

DEF 14A

Filing date
17 Apr 2026
Reporting date
17 Apr 2026
Next action
Verify source filing
PRE 14A File 001-36866

PRE 14A

Filing date
06 Apr 2026
Reporting date
06 Apr 2026
Next action
Verify source filing
4

FORM 4

Filing date
12 Jan 2026
Reporting date
08 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .